Evidence map›Paper›PMID 26732762›Full record

ArticleScience signaling2016

Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis.

Ismail Sergin, Somashubhra Bhattacharya, Roy Emanuel, Emel Esen, Carl J Stokes, Trent D Evans, Batool Arif, John A Curci, Babak Razani

Abstract read
In one paragraph

Article in Science signaling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Trehalose promotes atherosclerosis regression in female mice.Frontiers in cardiovascular medicine · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Mitochondrial quality control in health and cardiovascular diseases.Frontiers in cell and developmental biology · 2023
    Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ismail SerginCardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Somashubhra BhattacharyaCardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Roy EmanuelCardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Emel EsenDepartment of Orthopedic Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Carl J StokesCardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Trent D EvansCardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Batool ArifDepartment of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
John A CurciDepartment of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Babak RazaniCardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. brazani@im.wustl.edu.
Washington University in St. Louis · USVanderbilt University Medical Center · US

Funding

Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA^3CT )R01AG037120 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI BAXTER, BERNARD TIMOTHY, CURCI, JOHN A · 2011 to 2017
$12.2M
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSISR01HL125838 · NHLBI · WASHINGTON UNIVERSITY · PI RAZANI, BABAK · 2015 to 2025
$4.6M
De Novo Lipogenesis in Myocardial DysfunctionK08HL098559 · NHLBI · WASHINGTON UNIVERSITY · PI RAZANI, BABAK · 2010 to 2014
$589k
Characterization of a Lysosomal Acid Lipase Variant Associated with Coronary DiseaseF31HL132434 · NHLBI · WASHINGTON UNIVERSITY · PI EVANS, TRENT · 2016 to 2019
$114k
NHLBI NIH HHS 1R01HL125838NHLBI NIH HHS 5K08HL098559NHLBI NIH HHS F31 HL132434NHLBI NIH HHS K08 HL098559NHLBI NIH HHS R01 HL125838NIA NIH HHS 1R01AG037120NIA NIH HHS R01 AG037120
6 · The paper itself

Abstract

Autophagy is a catabolic cellular mechanism that degrades dysfunctional proteins and organelles. Atherosclerotic plaque formation is enhanced in mice with macrophages deficient for the critical autophagy protein ATG5. We showed that exposure of macrophages to lipids that promote atherosclerosis increased the abundance of the autophagy chaperone p62 and that p62 colocalized with polyubiquitinated proteins in cytoplasmic inclusions, which are characterized by insoluble protein aggregates. ATG5-null macrophages developed further p62 accumulation at the sites of large cytoplasmic ubiquitin-positive inclusion bodies. Aortas from atherosclerotic mice and plaques from human endarterectomy samples showed increased abundance of p62 and polyubiquitinated proteins that colocalized with plaque macrophages, suggesting that p62-enriched protein aggregates were characteristic of atherosclerosis. The formation of the cytoplasmic inclusions depended on p62 because lipid-loaded p62-null macrophages accumulated polyubiquitinated proteins in a diffuse cytoplasmic pattern. Lipid-loaded p62-null macrophages also exhibited increased secretion of interleukin-1β (IL-1β) and had an increased tendency to undergo apoptosis, which depended on the p62 ubiquitin-binding domain and at least partly involved p62-mediated clearance of NLRP3 inflammasomes. Consistent with our in vitro observations, p62-deficient mice formed greater numbers of more complex atherosclerotic plaques, and p62 deficiency further increased atherosclerotic plaque burden in mice with a macrophage-specific ablation of ATG5. Together, these data suggested that sequestration of cytotoxic ubiquitinated proteins by p62 protects against atherogenesis, a condition in which the clearance of protein aggregates is disrupted.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsApolipoproteins EApoptosisAtherosclerosisAutophagyAutophagy-Related Protein 5Carrier ProteinsCells, CulturedCytoplasmHeat-Shock ProteinsHumansImmunoblottingInclusion BodiesInflammasomesInterleukin-1betaAdaptor Proteins, Signal TransducingApolipoproteins EAtg5 protein, mouseAutophagy-Related Protein 5Carrier ProteinsHeat-Shock ProteinsInflammasomesInterleukin-1betaMicrotubule-Associated ProteinsNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mousePolyubiquitinSequestosome-1 ProteinSqstm1 protein, mouseUbiquitinated Proteins

Identifiers

PMID26732762
PMCPMC5023144
OpenAlexW2232236906

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.